Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-13-004824
Filing Date
2013-12-16
Accepted
2013-12-16 06:04:46
Documents
11
Period of Report
2013-10-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT nuvilex_10q-103113.htm 10-Q 281774
2 CERTIFICATION nuvilex_ex3101.htm EX-31.1 9785
3 CERTIFICATION nuvilex_ex3102.htm EX-31.2 9690
4 CERTIFICATION nuvilex_ex3201.htm EX-32.1 3596
5 CERTIFICATION nuvilex_ex3202.htm EX-32.2 3535
  Complete submission text file 0001019687-13-004824.txt   2283072

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE nvlx-20131031.xml EX-101.INS 234130
7 XBRL SCHEMA FILE nvlx-20131031.xsd EX-101.SCH 18181
8 XBRL CALCULATION FILE nvlx-20131031_cal.xml EX-101.CAL 38449
9 XBRL DEFINITION FILE nvlx-20131031_def.xml EX-101.DEF 51532
10 XBRL LABEL FILE nvlx-20131031_lab.xml EX-101.LAB 163570
11 XBRL PRESENTATION FILE nvlx-20131031_pre.xml EX-101.PRE 128089
Mailing Address 12510 PROSPERITY DRIVE, SUITE #310 SILVER SPRING MD 20904-1643
Business Address 12510 PROSPERITY DRIVE, SUITE #310 SILVER SPRING MD 20904-1643 (240) OWN-NVLX
NUVILEX, INC. (Filer) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 333-68008 | Film No.: 131277604
SIC: 2833 Medicinal Chemicals & Botanical Products